TransMedics Group, Inc. (NASDAQ:TMDX) is not on our list of 31 Most Popular Stocks Among Hedge Funds. As per our database, 29 hedge fund portfolios held TransMedics Group, Inc. (NASDAQ:TMDX) at the end of the second quarter which was 21 in the previous quarter. TransMedics Group, Inc.'s (NASDAQ:TMDX) total revenue in the second quarter of 2024 was $114.3 million, up 11.8% from Q1 2024 and 118% from Q2 2023. While we acknowledge the potential of TransMedics Group, Inc. (NASDAQ:TMDX) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.